AVITA Medical Past Earnings Performance
Past criteria checks 0/6
AVITA Medical's earnings have been declining at an average annual rate of -2.5%, while the Biotechs industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 37.2% per year.
Key information
-2.5%
Earnings growth rate
9.0%
EPS growth rate
Biotechs Industry Growth | -14.6% |
Revenue growth rate | 37.2% |
Return on equity | -72.1% |
Net Margin | -70.6% |
Next Earnings Update | 13 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How AVITA Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 50 | -35 | 66 | 21 |
30 Sep 23 | 45 | -34 | 59 | 17 |
30 Jun 23 | 41 | -31 | 53 | 17 |
31 Mar 23 | 37 | -26 | 48 | 15 |
31 Dec 22 | 34 | -27 | 45 | 14 |
30 Sep 22 | 32 | -30 | 44 | 15 |
30 Jun 22 | 30 | -30 | 43 | 14 |
31 Mar 22 | 32 | -29 | 41 | 15 |
31 Dec 21 | 33 | -25 | 38 | 16 |
30 Sep 21 | 31 | -22 | 34 | 15 |
30 Jun 21 | 29 | -27 | 37 | 15 |
31 Mar 21 | 23 | -35 | 42 | 13 |
31 Dec 20 | 18 | -44 | 50 | 11 |
30 Sep 20 | 16 | -49 | 54 | 11 |
30 Jun 20 | 14 | -42 | 49 | 9 |
31 Mar 20 | 12 | -36 | 43 | 8 |
31 Dec 19 | 11 | -28 | 35 | 7 |
30 Sep 19 | 8 | -23 | 29 | 7 |
30 Jun 19 | 5 | -25 | 28 | 8 |
31 Mar 19 | 4 | -22 | 27 | 6 |
31 Dec 18 | 2 | -18 | 17 | 10 |
30 Sep 18 | 1 | -15 | 15 | 10 |
30 Jun 18 | 1 | -13 | 16 | 6 |
31 Mar 18 | 1 | -12 | 12 | 8 |
31 Dec 17 | 1 | -11 | 12 | 7 |
30 Sep 17 | 1 | -10 | 11 | 6 |
30 Jun 17 | 1 | -9 | 11 | 5 |
31 Mar 17 | 1 | -8 | 10 | 4 |
31 Dec 16 | 1 | -7 | 8 | 3 |
30 Sep 16 | 1 | -8 | 9 | 3 |
30 Jun 16 | 1 | -8 | 8 | 3 |
31 Mar 16 | 1 | -8 | 7 | 3 |
31 Dec 15 | 1 | -7 | 5 | 3 |
30 Sep 15 | 1 | -6 | 5 | 3 |
30 Jun 15 | 1 | -6 | 4 | 3 |
31 Mar 15 | 1 | -5 | 4 | 2 |
31 Dec 14 | 1 | -5 | 5 | 2 |
30 Sep 14 | 2 | -5 | 6 | 2 |
30 Jun 14 | 3 | -5 | 7 | 2 |
31 Mar 14 | 3 | -6 | 7 | 2 |
31 Dec 13 | 3 | -7 | 8 | 2 |
30 Sep 13 | 3 | -7 | 8 | 2 |
30 Jun 13 | 3 | -7 | 8 | 2 |
Quality Earnings: 51KB is currently unprofitable.
Growing Profit Margin: 51KB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 51KB is unprofitable, and losses have increased over the past 5 years at a rate of 2.5% per year.
Accelerating Growth: Unable to compare 51KB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 51KB is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-11.5%).
Return on Equity
High ROE: 51KB has a negative Return on Equity (-72.12%), as it is currently unprofitable.